Rikin Shah

Just adding on to the question for Indichem. So once the plant commissions, what would be your typical time line in terms of trials, vendor cycle approval and ramp up? Basically, are we expecting any sort of delay or time to be dedicated for this?

Okay. Got it. And in terms of the type of products that we manufacture in Indichem, what is something that we are going to be doing here apart from photoresist chemicals that we do for BFC? Or are we going to be targeting a similar line of products here?

Sure. In our electrolyte subsidiary, we have sort of had a dilution and given 10% stake to ARZ. Can you explain the sort of rationale here? And what are we thinking, broader term, for this?